Javascript must be enabled to continue!
Design, development and in vivo pharmacokinetic of telmisartan loaded oral disintegration tablets
View through CrossRef
Orodispersible Tablets (ODT) is a novel tableting technology which is formulated, and it overcomes the difficulties of other multi compressed tablets. Telmisartan has a bioavailability of 42-100 percent and a 24-hour elimination half-life. It excretes the majority of drugs through the faeces, which accounts for 97 percent of total drug excretion. The objective of this research is to formulate and evaluate Telmisartan loaded ODT and to prove the enhancement of dissolution and bioavailability of Telmisartan. From the DSC studies, it was confirmed that Telmisartan and excipients used in the formulation are compatible to each other and suitable for the manufacturing process. Telmisartan loaded ODT was formulated by wet granulation technique and evaluated for powder characteristics and release characteristics. About 9 formulations were formulated in each ODT, and all the formulation obeys a good powder flow characteristic from the angle of repose, Carr’s index and Hausner’s ratio. All the experimental formulation batches have been subjected to various evaluations viz, average weight, friability, disintegration, thickness, hardness, dissolution, content uniformity. Among this nine Telmisartan ODT formulations (F1-F9), F7 possess an expected release pattern and disintegration time in a short time period (i.e., 101.8 ± 2.72 in 5th min and disintegration time at 5 seconds), which may fastens the absorption and bioavailability of Telmisartan. It was concluded that ODT was a suitable dosage form to enhance the solubility at the same time the bioavailability of BCS class II drugs like Telmisartan.
Title: Design, development and in vivo pharmacokinetic of telmisartan loaded oral disintegration tablets
Description:
Orodispersible Tablets (ODT) is a novel tableting technology which is formulated, and it overcomes the difficulties of other multi compressed tablets.
Telmisartan has a bioavailability of 42-100 percent and a 24-hour elimination half-life.
It excretes the majority of drugs through the faeces, which accounts for 97 percent of total drug excretion.
The objective of this research is to formulate and evaluate Telmisartan loaded ODT and to prove the enhancement of dissolution and bioavailability of Telmisartan.
From the DSC studies, it was confirmed that Telmisartan and excipients used in the formulation are compatible to each other and suitable for the manufacturing process.
Telmisartan loaded ODT was formulated by wet granulation technique and evaluated for powder characteristics and release characteristics.
About 9 formulations were formulated in each ODT, and all the formulation obeys a good powder flow characteristic from the angle of repose, Carr’s index and Hausner’s ratio.
All the experimental formulation batches have been subjected to various evaluations viz, average weight, friability, disintegration, thickness, hardness, dissolution, content uniformity.
Among this nine Telmisartan ODT formulations (F1-F9), F7 possess an expected release pattern and disintegration time in a short time period (i.
e.
, 101.
8 ± 2.
72 in 5th min and disintegration time at 5 seconds), which may fastens the absorption and bioavailability of Telmisartan.
It was concluded that ODT was a suitable dosage form to enhance the solubility at the same time the bioavailability of BCS class II drugs like Telmisartan.
Related Results
Effects Of angiotensin II and Telmisartan on transient outward potassium and L-type calcium currents in Sprague–Dawley rat atrial myocytes
Effects Of angiotensin II and Telmisartan on transient outward potassium and L-type calcium currents in Sprague–Dawley rat atrial myocytes
Objective
To explore possible electrophysiological mechanisms of single atrial myocyte by evaluating the effects of angiotensinII (AngII) and telmisartan on trans...
MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells
MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells
Background:
Pancreatic ductal adenocarcinoma (PDAC) is the most devastating of all cancers with an extremely poor prognosis. It has few effective and reliable therapeut...
Comparative Study of Olmesartan versus Telmisartan, in Patient with Stage I Hypertension
Comparative Study of Olmesartan versus Telmisartan, in Patient with Stage I Hypertension
Background: Hypertension is one of the most common diseases in the world. It is defined as sustained increase in blood pressure ≥ 140/90 mmHg. The risk of both microvascular & ...
Disintegration Characteristics of Remolded Granite Residual Soil with Different Moisture Contents
Disintegration Characteristics of Remolded Granite Residual Soil with Different Moisture Contents
Granite residual soil (GRS) has prominent disintegration characteristics which have induced various geological disasters and engineering problems. The initial moisture content is b...
Telmisartan can promote spermatogenesis in irradiated mice by inhibiting ESR1 protein degradation in Sertoli cells
Telmisartan can promote spermatogenesis in irradiated mice by inhibiting ESR1 protein degradation in Sertoli cells
I.Background: Male infertility is a global issue with few remedies,
particularly for testicular damage caused by radiation. Investigating
new medications to treat radiation-induced...
Comparative Study to Evaluate Efficacy & Cost Effectiveness of Olmesartanversus Telmisartan, In Patients of Stage I Hypertension
Comparative Study to Evaluate Efficacy & Cost Effectiveness of Olmesartanversus Telmisartan, In Patients of Stage I Hypertension
Background: Hypertension is one of the most common diseases in the world. It is an important and independent risk factor for atherosclerosis, heart failure, renal disease, and peri...
COMPARATIVE STUDY ON THE BENEFICIAL EFFECTS OF TELMISARTAN AND OTHER ANTIHYPERTENSIVE AGENTS IN STROKE PATIENTS
COMPARATIVE STUDY ON THE BENEFICIAL EFFECTS OF TELMISARTAN AND OTHER ANTIHYPERTENSIVE AGENTS IN STROKE PATIENTS
<p class="ParaAttribute0">Objective<strong>:</strong> To compare the beneficial effects of telmisartan with other anti-hypertensive agents during stroke with resp...
Single-Cell Transcriptomics Reveals Immune Modulation by Telmisartan in Colorectal Cancer
Single-Cell Transcriptomics Reveals Immune Modulation by Telmisartan in Colorectal Cancer
Telmisartan, an angiotensin II type 1 receptor blocker with established anti-inflammatory and antihypertensive properties, has been reported to inhibit tumor cell proliferation, ye...

